Key result
Catheter ablation for atrial fibrillation guided by CartoMerge did not significantly decrease the risk of recurrences compared with Carto (RR 0.76; 95% CI 0.55-1.04; P=0.09).
Why the study?
Does catheter ablation guided by CartoMerge reduce atrial fibrillation recurrence and major complications in patients with atrial fibrillation compared to Carto?
Meta-Analysis
Does catheter ablation guided by CartoMerge reduce atrial fibrillation recurrence and major complications in patients with atrial fibrillation compared to Carto?
Relative Risk: 0.76 (95% CI 0.55–1.04)
p-value: p=0.09
Image integration using CartoMerge does not significantly improve clinical outcomes or reduce complications compared to standard Carto mapping for atrial fibrillation ablation in experienced centers.
CartoMerge guidance does not reduce AF recurrences versus standard Carto; supports simpler mapping without image integration in experienced centers.
BACKGROUND: Studies comparing the procedural and clinical outcomes of catheter ablation for atrial fibrillation (AF) guided by CartoMerge and that by Carto have achieved mixed results (Carto, Biosense Webster, Diamond Bar, CA, USA). We collected these studies and conducted a meta-analysis to determine whether CartoMerge results in better procedural and clinical outcomes. METHODS AND RESULTS: Three randomized controlled trials and two controlled observational studies were collected for analysis. The clinical and procedural outcomes of interest were AF recurrence after catheter ablation, major complications, procedure durations, and fluoroscopy time. Meta-analysis was performed using RevMan 5.0.18 software (The Cochrane Collaboration, Copenhagen, Denmark) and pooled estimates of effect were reported as risk ratios with 95% confidence intervals (CI). The overall results of this meta-analysis indicate that catheter ablation for AF guided by CartoMerge is insignificantly associated with a decreased risk of recurrences (RR = 0.76; 95% CI: 0.55-1.04; P = 0.09) and major complications (RR = 0.73; 95% CI: 0.37-1.45; P = 0.37) compared with that by Carto. CONCLUSION: The image integration using CartoMerge guiding catheter ablation for AF does not improve the main clinical outcomes significantly compared with that by Carto in centers with experienced operators.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2012) conducted a meta-analysis in Atrial fibrillation. Catheter ablation guided by CartoMerge vs. Catheter ablation guided by Carto was evaluated on Atrial fibrillation recurrence (RR 0.76, 95% CI 0.55-1.04, p=0.09). Catheter ablation for atrial fibrillation guided by CartoMerge did not significantly decrease the risk of recurrences compared with Carto (RR 0.76; 95% CI 0.55-1.04; P=0.09).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: